Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Non-Current Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Total Non-Current Liabilities ₹17 Cr₹7.87 Cr₹3.19 Cr₹3.28 Cr₹1.79 Cr

What is the latest Total Non-Current Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Total Non-Current Liabilities ratio of NATH BIOGENES (INDIA) is ₹17 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹17 Cr
Mar2024₹7.87 Cr
Mar2023₹3.19 Cr
Mar2022₹3.28 Cr
Mar2013₹1.79 Cr

How is Total Non-Current Liabilities of NATH BIOGENES (INDIA) Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹17 Cr
110.04
Mar2024 ₹7.87 Cr
146.55
Mar2023 ₹3.19 Cr
-2.60
Mar2022 ₹3.28 Cr
82.96
Mar2013 ₹1.79 Cr -

Compare Total Non-Current Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹372.4 Cr 15.3% 51.2% 8.9% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,472.1 Cr 0.3% 9.1% -20.9% Stock Analytics
KAVERI SEED COMPANY ₹4,960.0 Cr 2.5% 21.8% -35.1% Stock Analytics
VENKYS (INDIA) ₹2,232.1 Cr 4.4% 30.5% -7.8% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,033.1 Cr -3.6% 46.1% -27.8% Stock Analytics
INDO US BIOTECH ₹210.6 Cr 2.5% 4.9% -39.3% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

15.3%

51.2%

8.9%

SENSEX

-1%

2.2%

-3.6%


You may also like the below Video Courses